Thermo Fisher Scientific (TMO) Competitors $416.35 -1.64 (-0.39%) As of 01:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Is MEDP or TMO more profitable? Medpace has a net margin of 19.31% compared to Thermo Fisher Scientific's net margin of 15.19%. Medpace's return on equity of 54.36% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Medpace19.31% 54.36% 20.81% Thermo Fisher Scientific 15.19%17.15%8.47% Do analysts recommend MEDP or TMO? Medpace presently has a consensus price target of $344.82, indicating a potential upside of 10.62%. Thermo Fisher Scientific has a consensus price target of $600.30, indicating a potential upside of 43.88%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 0 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.21Thermo Fisher Scientific 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has preferable earnings & valuation, MEDP or TMO? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.16B4.15$404.39M$13.1023.79Thermo Fisher Scientific$42.88B3.67$6.34B$17.0524.47 Does the media refer more to MEDP or TMO? In the previous week, Thermo Fisher Scientific had 53 more articles in the media than Medpace. MarketBeat recorded 74 mentions for Thermo Fisher Scientific and 21 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.10 beat Medpace's score of 0.98 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 10 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 43 Very Positive mention(s) 10 Positive mention(s) 14 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, MEDP or TMO? Medpace has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Do institutionals and insiders believe in MEDP or TMO? 78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryThermo Fisher Scientific beats Medpace on 10 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$157.49B$6.65B$5.56B$20.60BDividend Yield0.40%1.20%4.23%3.65%P/E Ratio24.4725.4828.6127.20Price / Sales3.6787.29437.4953.52Price / Cash14.1620.3636.0222.28Price / Book3.224.648.184.58Net Income$6.34B$174.76M$3.23B$995.22M7 Day Performance-0.54%-1.50%-0.25%-1.09%1 Month Performance2.98%0.92%5.40%3.25%1 Year Performance-24.89%2.17%26.35%6.97% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.9917 of 5 stars$416.35-0.4%$600.30+44.2%-23.1%$157.27B$42.88B24.44125,000Positive NewsUpcoming EarningsDividend AnnouncementMEDPMedpace4.2443 of 5 stars$321.47-0.6%$344.82+7.3%-29.6%$9.23B$2.11B24.515,900Upcoming EarningsAAgilent Technologies4.8112 of 5 stars$120.66-2.1%$139.77+15.8%-13.6%$34.23B$6.51B29.7617,900AMNAMN Healthcare Services4.2386 of 5 stars$20.75-1.9%$32.08+54.6%-61.5%$793.76M$2.85B-4.792,968Gap UpDHRDanaher4.97 of 5 stars$199.00-2.9%$248.43+24.8%-21.7%$142.05B$23.88B38.5463,000Positive NewsUpcoming EarningsHAEHaemonetics4.886 of 5 stars$76.13+0.8%$97.30+27.8%-17.3%$3.66B$1.36B23.003,023Analyst RevisionMCKMcKesson4.571 of 5 stars$715.92+0.9%$706.83-1.3%+23.0%$89.55B$359.05B27.7145,000Positive NewsAnalyst DowngradeInsider TradeQGENQiagen3.6818 of 5 stars$48.31+0.4%$49.40+2.3%+16.7%$10.73B$1.98B121.055,765WSTWest Pharmaceutical Services4.7896 of 5 stars$225.22-0.9%$320.00+42.1%-31.0%$16.17B$2.89B35.3410,600Positive NewsMTDMettler-Toledo International4.0803 of 5 stars$1,202.47-1.8%$1,280.90+6.5%-14.2%$24.97B$3.83B29.9717,300Positive NewsWATWaters4.8742 of 5 stars$310.36-12.1%$388.94+25.3%-4.3%$18.45B$2.98B28.137,600Trending NewsAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
